Skip to content

Retrospective study of butylphthalein in the treatment of ischemic stroke

Retrospective study of butylphthalein in the treatment of ischemic stroke

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400093938
Enrollment
Unknown
Registered
2024-12-13
Start date
2024-11-04
Completion date
Unknown
Last updated
2024-12-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with acute ischemic stroke

Interventions

Butylphthalide Treatment Group:NA

Sponsors

The Second Affiliated Hospital of Soochow University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Acute ischemic stroke with past and/or current use of butylphthalein (softgel or injection)

Exclusion criteria

Exclusion criteria: Patients who have not used butylphthalein

Design outcomes

Primary

MeasureTime frame
Incidence: Overall AEs, ADRs, AEs incidence of death outcomes; Duration of medication: average duration of medication, longest duration of medication, shortest duration of medication; Drug users: average age, gender, average weight; Related to drug use: reasons for drug use, reasons for discontinuation, outcomes after drug use;;Duration of medication: average duration of medication, longest duration of medication, shortest duration of medication;Population: Mean age, sex, mean weight;Related to medication: reasons for medication, reasons for discontinuation, outcomes after medication;

Secondary

MeasureTime frame
Analysis of AI Technology on Post-Marketing Study Quality and Efficiency;

Countries

China

Contacts

Public ContactChunfeng Liu

The Second Affiliated Hospital of Soochow University

liuchunfeng@suda.edu.cn+86 136 0621 0609

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026